Our findings demonstrate that basal LH, along with other hormonal markers such as IGF-1, IGFBP-3, and DHEAs, are robust indicators for diagnosing CPP, potentially reducing the need for invasive stimulation tests. The gene discussed is IGFBP3; the disease is central precocious puberty.